The legacy success of sildenafil has undeniably influenced the pharmaceutical landscape. However, putting money in companies heavily dependent on biosimilars and the diminishing patent rights surrounding https://digibookmarks.com/story21330338/the-blue-pill-and-drugmakers-a-risky-venture